Value through Innovation27 July 2016

What is a lay summary?

Clinical Study Results

  • BI 695500 - Lymphoma, Follicular
    Clinical Study Number 1301.5
    Study Indication Lymphoma, Follicular
    Product BI 695500
    Generic Name BI 695500
    Lab Code BI 695500
    Clinical Phase I
    Study Title

    A randomized, double-blind, parallel-arm, Phase I study to evaluate pharmacokinetics and pharmacodynamics of BI 695500 vs. rituximab (MabThera®) induction immunotherapy as firstline treatment in patients with low tumor burden follicular lymphoma.

    Study Document
    Trial synopsis 1301.5 english